Skip to Main Content

Paper Details

Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers.
Nat Commun
5
2023
Patients, TP53, Wnt, bowel cancers, cancer, colitis-associated cancers, dysplasia, dysplasia/cancer, inflammation, inflammatory bowel disease, lesions, mouse, mouse models, neoplastic bowel lesions, patients, synchronous or isolated dysplasia
Author NameAffiliation
Walid K ChatilaTri-Institutional Program in Computational Biology and Medicine
Walid K ChatilaMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Elisa de StanchinaMemorial Sloan Kettering Cancer Center
Elisa de StanchinaMemorial Sloan Kettering Cancer Center
Manish A Shah
Adam J BassHerbert Irving Comprehensive Cancer Research Center, Columbia University Irving Medical Center
Nikolaus SchultzMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
  • 1 - 12

Datasets

Release 1.2